Serum CCL17 levels have been shown to correlate with disease activity in various inflammatory and neoplastic skin diseases, including atopic dermatitis, bullous pemphigoid, and CTCL. Here, CCL17 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.